Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma

Clinical trial NCT00443976 · COMPLETED

Trial details

NCT number: NCT00443976
Sponsor: NCIC Clinical Trials Group
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkins Lymphoma Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2007-01-30
Primary completion: 2010-04-09
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.